Expression of tumoral FOXP3 in gastric adenocarcinoma is associated with favorable clinicopathological variables and related with Hippo pathway

被引:3
作者
Suh, Jung-Ho [1 ]
Won, Kyu Yeoun [2 ]
Kim, Gou Young [2 ]
Bae, Go Eun [2 ]
Lim, Sung-Jig [2 ]
Sung, Ji-Youn [3 ]
Park, Yong-Koo [3 ]
Kim, Youn Wha [3 ]
Lee, Juhie [3 ]
机构
[1] Kyung Hee Univ, Grad Sch Med, Dept Internal Med, Seoul 134727, South Korea
[2] Kyung Hee Univ, Kyung Hee Univ Hosp Gangdong, Sch Med, Dept Pathol, Seoul 134727, South Korea
[3] Kyung Hee Univ, Kyung Hee Univ Hosp, Sch Med, Dept Pathol, Seoul 134727, South Korea
关键词
Gastric adenocarcinoma; FOXP3; Lats2; YAP; REGULATORY T-CELLS; TRANSCRIPTION FACTOR FOXP3; BREAST-CANCER; LUNG-CANCER; HEPATOCELLULAR-CARCINOMA; SUPPRESSOR; PROGRESSION; RECURRENCE; REPRESSOR; ONCOGENE;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
FOXP3 is a transcription factor and well-known hallmark of immune suppressive T regulatory cells (Tregs). Recent studies indicate that, in addition to its association with Treg function in the immune system, FOXP3 plays an important role in tumor development. And important tumor suppressor relay between the FOXP3 and Hippo pathways was found in human cancer. Thus, we investigated tumoral FOXP3, infiltrated Tregs count, Lats2, and YAP expression in gastric adenocarcinoma, and the relationships between expression of these three proteins and p53, Ki67, and other clinicopathological variables. We used 118 gastric adenocarcinoma tissues via immunohistochemical analysis, using a tissue microarray, in relation to survival and other clinicopathological factors. We report the several novel observations about the relationship between tumoral FOXP3 and Hippo pathway components in gastric adenocarcinoma. Positive tumoral FOXP3 expression was significantly related with smaller tumor size, tubular tumor type, lower histological grade, lower T stage, lower recurrence rate, less lymphatic invasion, and less neural invasion. Furthermore, patients with positive tumoral FOXP3 experienced significantly better disease-free and overall survival compared to patients with negative tumoral FOXP3. These findings show that tumoral FOXP3 expression is associated with favorable clinicopathological variables in gastric adenocarcinoma. And we report the novel observation of a relationship between tumoral FOXP3 and Hippo pathway components in gastric adenocarcinoma. Tumoral FOXP3 expression, infiltrated Tregs count, and Lats2 expression were all positively correlated with YAP expression. These findings suggest that the Hippo pathway in gastric adenocarcinoma might be influenced by both tumoral FOXP3 and infiltrated Tregs. In conclusion, the loss of FOXP3 expression in cancer cells is thought to contribute to tumorigenesis and progression of gastric adenocarcinoma. The expression of FOXP3 in gastric adenocarcinoma is related with Lats2 and YAP expression of the Hippo pathway.
引用
收藏
页码:14608 / 14618
页数:11
相关论文
共 36 条
[1]   Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse [J].
Bates, Gaynor J. ;
Fox, Stephen B. ;
Han, Cheng ;
Leek, Russell D. ;
Garcia, Jose F. ;
Harris, Adrian L. ;
Banham, Alison H. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (34) :5373-5380
[2]   X-linked syndrome of polyendocrinopathy, immune dysfunction, and diarrhea maps to Xp11.23-Xq13.3 [J].
Bennett, CL ;
Yoshioka, R ;
Kiyosawa, H ;
Barker, DF ;
Fain, PR ;
Shigeoka, AO ;
Chance, PF .
AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 66 (02) :461-468
[3]   Immunosuppressive regulatory T cells are associated with aggressive breast cancer phenotypes: a potential therapeutic target [J].
Bohling, Sandra D. ;
Allison, Kimberly H. .
MODERN PATHOLOGY, 2008, 21 (12) :1527-1532
[4]   Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival [J].
Curiel, TJ ;
Coukos, G ;
Zou, LH ;
Alvarez, X ;
Cheng, P ;
Mottram, P ;
Evdemon-Hogan, M ;
Conejo-Garcia, JR ;
Zhang, L ;
Burow, M ;
Zhu, Y ;
Wei, S ;
Kryczek, I ;
Daniel, B ;
Gordon, A ;
Myers, L ;
Lackner, A ;
Disis, ML ;
Knutson, KL ;
Chen, LP ;
Zou, WP .
NATURE MEDICINE, 2004, 10 (09) :942-949
[5]   The regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells [J].
Ebert, Lisa M. ;
Tan, Bee Shin ;
Browning, Judy ;
Svobodova, Suzanne ;
Russell, Sarah E. ;
Kirkpatrick, Naomi ;
Gedye, Craig ;
Moss, Denis ;
Ng, Sweet Ping ;
MacGregor, Duncan ;
Davis, Ian D. ;
Cebon, Jonathan ;
Chen, Weisan .
CANCER RESEARCH, 2008, 68 (08) :3001-3009
[6]   Regulatory T cell lineage specification by the forkhead transcription factor FoxP3 [J].
Fontenot, JD ;
Rasmussen, JP ;
Williams, LM ;
Dooley, JL ;
Farr, AG ;
Rudensky, AY .
IMMUNITY, 2005, 22 (03) :329-341
[7]   Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection [J].
Gao, Qiang ;
Qiu, Shuang-Jian ;
Fan, Jia ;
Zhou, Jian ;
Wang, Xiao-Ying ;
Xiao, Yong-Sheng ;
Xu, Yang ;
Li, Yi-Wei ;
Tang, Zhao-You .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18) :2586-2593
[8]   The Salvador-Warts-Hippo pathway - an emerging tumour-suppressor network [J].
Harvey, Kieran ;
Tapon, Nicolas .
NATURE REVIEWS CANCER, 2007, 7 (03) :182-191
[9]   Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer [J].
Hinz, Sebastian ;
Pagerols-Raluy, Laia ;
Oberg, Hans-Heinrich ;
Ammerpohl, Ole ;
Gruessel, Sandra ;
Sipos, Bence ;
Gruetzmann, Robert ;
Pilarskys, Christian ;
Ungefroren, Hendrik ;
Saeger, Hans-Detlev ;
Mloeppel, Guenter ;
Kabelitz, Dieter ;
Kalthoff, Holger .
CANCER RESEARCH, 2007, 67 (17) :8344-8350
[10]   Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinorna and its premalignant lesions [J].
Hiraoka, Nobuyoshi ;
Onozato, Kaoru ;
Kosuge, Tomoo ;
Hirohashi, Setsuo .
CLINICAL CANCER RESEARCH, 2006, 12 (18) :5423-5434